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ﻫﺎ در  ي ﺳﺎزوﻛﺎر ﻏﻴﺮﻋﺎدي ﺳﻠﻮل ﻣﻴﺮ در ﺟﻬﺎن، ﻧﺘﻴﺠﻪ و ﺗﺮﻳﻦ دﻻﻳﻞ ﻣﺮگ ﻳﻜﻲ از اﺻﻠﻲ 1ﺗﻮﻣﻮر: ﻣﻘﺪﻣﻪ
ﻫﺎ ﺑﻪ ﺳﻤﺖ  ﻫﺎ اﺛﺮ ﺑﮕﺬارﻧﺪ ﺗﺎ آن ﺗﻮاﻧﻨﺪ ﺑﺮ ﺳﻠﻮل ﻋﻮاﻣﻞ ﻣﺨﺘﻠﻒ زﻳﺎدي ﻣﻲ رﺷﺪ و ﺗﻘﺴﻴﻢ اﺳﺖ و
ﺷﻮد  ﺗﺮﻳﻦ ﻧﻘﺎط داﺧﻞ ﺳﻠﻮل ﻛﻪ ﻣﺮﺑﻮط ﺑﻪ ﺑﺨﺶ رﺷﺪ و ﺗﻘﺴﻴﻢ اﺳﺖ، ﻣﻲ ﺳﺮﻃﺎﻧﻲ ﺷﺪن ﺑﺮوﻧﺪ. از ﻣﻬﻢ
 اﺳﺖ. 2C ROTmو 1C ROTmﻫﺎي  اﺷﺎره ﻛﺮد ﻛﻪ ﺷﺎﻣﻞ دو ﻣﺠﻤﻮﻋﻪ ﺑﻪ اﺳﻢ 2ROTmﻫﺎي  ﺑﻪ ﮔﻴﺮﻧﺪه
اﻧﺪ ﻛﻪ ﺗﻮاﻧﺎﻳﻲ ﻣﻬﺎر ﻫﻤﺰﻣﺎن اﻳﻦ دو ﮔﻴﺮﻧﺪه را دارﻧﺪ و ﻣﻬﺎر ﻫﻤﺰﻣﺎن اﻳﻦ  ﺷﺪه ﺗﺮﻛﻴﺒﺎت ﻣﺨﺘﻠﻔﻲ ﺷﻨﺎﺳﺎﻳﻲ
  روﻳﻪ دارد.  دو ﮔﻴﺮﻧﺪه، اﺛﺮ ﻗﺎﺑﻞ ﻗﺒﻮﻟﻲ در ﻛﻨﺘﺮل رﺷﺪ و ﺗﻘﺴﻴﻢ ﺑﻲ
از ﻛﻨﺪ ﻛﻪ ﺑﺘﻮان  ، ﻛﻤﻚ ﻣﻲي ﻛﺸﻒ دارو ﺷﺪه اﺳﺖ ﻳﻚ ﺑﺨﺶ ﺑﺰرﮔﻲ از ﭘﺮوﺳﻪ ﻛﻪ ﮕﺮي ﻣﺠﺎزيﻏﺮﺑﺎﻟ
  .ﻣﺸﺎﺑﻪ ﺑﺎ ﺗﺮﻛﻴﺐ دﻟﺨﻮاه را ﭘﻴﺪا ﻛﺮد، ﺗﺮﻛﻴﺒﺎت ﻫﺎ ﺗﺮﻛﻴﺐ ﻣﺘﻔﺎوت ﺑﻴﻦ ﻣﻴﻠﻴﻮن
 2C ROTmو   1C ROTmي  ﻫﺎي دوﮔﺎﻧﻪ ﻣﻮﻟﻜﻮل ﻛﻪ ﻣﻬﺎرﻛﻨﻨﺪه 5ﻛﺎر  ﺑﺮاي اﻳﻦ :ﻫﺎ ﻣﻮاد و روش
دﺳﺖ آﻣﺪ. ﺳﭙﺲ اﻳﻦ ﻧﻘﺎط ﻓﺎرﻣﺎﻛﻮﻓﻮري ﻣﺸﺘﺮك ﺑﻪ  ﻫﺎ ﺑﻪ ﺑﻮدﻧﺪ اﻧﺘﺨﺎب ﺷﺪﻧﺪ و ﻓﺎرﻣﺎﻛﻮﻓﻮر ﻣﺸﺘﺮك آن
آﻏﺎز ﺷﺪ و ﺳﭙﺲ ﺑﻴﻦ  elbasahcruP CNIZه ﭘﺎﻳﮕﺎه دادﺷﺪﻧﺪ و ﺟﺴﺘﺠﻮ در  در ﻧﻈﺮ ﮔﺮﻓﺘﻪ ﻣﺮﺟﻊﻋﻨﻮان 
ﻣﻮﻟﻜﻮل ﻛﻪ ﺿﺮﻳﺐ  12، ﺷﺒﺎﻫﺖ ﺳﻨﺠﻲ اﻧﺠﺎم ﺷﺪ و ﺗﻌﺪاد از اﻳﻦ ﻣﺮﺣﻠﻪ دﺳﺖ آﻣﺪه ﻣﻮﻟﻜﻮل ﺑﻪ 2838
ﻣﻮﻟﻜﻮل ﺑﺮ روي  12اﻧﺘﺨﺎب ﺷﺪﻧﺪ.  3ﻣﻮﻟﻜﻮﻟﻲ داﺷﺘﻨﺪ ﺑﺮاي ﻋﻤﻠﻴﺎت داﻛﻴﻨﮓ 0/58ﺑﺎﻻي  otominaT
ﺑﻴﺸﺘﺮ  ﻴﻨﮓﻣﻮﻟﻜﻮﻟﻲ ﻛﻪ اﻧﺮژي داﻛ 01ﺷﺪﻧﺪ و  4داك )PAF3 :DI BDP( BRF & 21PBKF ﭘﺮوﺗﺌﻴﻦ 
  و ﺑﻬﺘﺮي داﺷﺘﻨﺪ اﻧﺘﺨﺎب ﺷﺪﻧﺪ.
                                                 
  romuT ١
 nicymapar fo tegrat nailammaM ٢
 gnikcod raluceloM ٣
 kcoD ٤
ﻪﺘﻓﺎﻳ ﺎﻫ :10 ﻲﻣ رﺎﻈﺘﻧا ﻪﻛ ﺪﻳﺪﺟ لﻮﻜﻟﻮﻣ هﺪﻧﺮﻴﮔ رﺎﻬﻣ ﻲﻳﺎﻧاﻮﺗ دور  يﺎﻫmTOR C1   وmTOR C2  ار
.ﺪﻧﺪﺷ ﻲﻓﺮﻌﻣ ،ﺪﻨﺷﺎﺑ ﻪﺘﺷاد  
ﻪﺠﻴﺘﻧ يﺮﻴﮔلﻮﻜﻟﻮﻣ : ﻲﻓﺮﻌﻣ ﻲﻳﺎﻬﻧ يﺎﻫ ﻛاد يژﺮﻧا يدراﻮﻣ رد هﺪﺷﮓﻨﻴ  زا يﺮﺘﺸﻴﺑ5 لﻮﻜﻟﻮﻣ  ﻪﻴﻟوا
.ﺪﻨﺘﺷاد  
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English Abstract  
Introduction: Tumor, one of the main reasons of death in the world, is the 
result of abnormal cell growth and proliferation. A lot of different factors 
can effect on the cells to become cancerous side. One of the most important 
parts of cells that are related to the growth and proliferation, are mTOR 
complexes. There are two types of mTOR named mTOR C1 and mTOR 
C2. Many different compounds have been identified that they can inhibit  
mTOR complexes and therefore they have good result on growth and 
proliferation control. Virtual screening methods, which have today become 
a large part of the drug discovery process, help us to find novel compounds 
and chemotypes. 
Materials and Methods: Five dual inhibitors of mTORC1 and mTORC2 
were selected and their common pharmacophore was detected. The points 
of common pharmacophores were used as the query for search in ZINC 
database and 8382 molecules were obtained. Then, the similarity search was 
carried out and 21 molecules that were on top of the Tanimoto coefficient 
of 0,85, were selected for the docking operation. Twenty one selected 
molecules were docked on FKBP12 & FRB (PDB ID: 3FAP) protein. 
Finally, 10 molecules that had more and better dock fitness, as a result were 
introduced. 
Results: 10 new molecules which are expected to inhibit mTORC1 and 
mTORC2, were introduced. 
Conclusion: The final introduced molecules in cases have more fitness 
score than the primary effective structures.  
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